Contact this trialFirst, we need to learn more about you.
Behavioural Intervention
Nicotinamide Riboside for Systemic Lupus Erythematosus (SLE)
Recruiting0 awardsPhase 1 & 2
Bethesda, Maryland
This trial will assess the effect of NR on blunting type 1 IFN signaling and bioenergetic/immunometabolic profiles in SLE women to modulate metabolic pathways and endothelial dysfunction.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.